SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from CardioVascular BioTherapeutics, Inc. (CIK 0001303497) — Feb 9, 2005

CardioVascular BioTherapeutics, Inc. (CIK 0001303497)
Date: Feb. 9, 2005 · CIK: 0001303497 · Accession: 0001193125-05-023527

AI Filing Summary & Sentiment

File numbers found in text: 333-119199

Date
February 9, 2005
Author
As Representative
Form
CORRESP
Company
CardioVascular BioTherapeutics, Inc. (CIK 0001303497)

Letter

Securities and Exchange Commission Division of Corporation Finance Attention: Greg Belliston Re: CardioVascular BioTherapeutics, Inc. Registration Statement on Form S-1 File No. 333-119199

Dear Mr. Belliston:

With respect to the above-referenced Registration Statement on Form S-1 (the “Registration Statement”), the following information regarding the distribution of the prospectus dated September 23, 2004, prospectuses dated January 13, 2005 and the prospectus dated February 4, 2005 is hereby furnished to the Commission pursuant to Rule 460 of the Rules and Regulations of the Commission under the Securities Act of 1933, as amended, in connection with the request for acceleration of the effective date of the Registration Statement.

The number of prospectuses dated September 23, 2004, prospectuses dated January 13, 2005 and the prospectuses dated February 4, 2005 as distributed between September 23, 2004 and February 8, 2005 is as follows:

No. of copies dated September 23, 2004

No. of copies dated January 13, 2005

No. of copies dated February 4, 2005

To Prospective Underwriters and Dealers:

2,184

2,184

2,184

To Institutions:

To Individuals:

Total:

2,704

2,704

2,713

Sincerely,
FIRST DUNBAR SECURITIES CORPORATION

Show Raw Text
CORRESP
1
filename1.htm

SEC Response Letter

 February 9, 2005

 Securities and Exchange Commission

 Division of Corporation Finance

 Judiciary Plaza

 450 Fifth Street, N.W.

 Washington, D.C. 20549

 Attention: Greg Belliston

Re:
CardioVascular BioTherapeutics, Inc.

Registration Statement on Form S-1

File No. 333-119199

 Dear Mr. Belliston:

 With
respect to the above-referenced Registration Statement on Form S-1 (the “Registration Statement”), the following information regarding the distribution of the prospectus dated September 23, 2004, prospectuses dated January 13, 2005 and the
prospectus dated February 4, 2005 is hereby furnished to the Commission pursuant to Rule 460 of the Rules and Regulations of the Commission under the Securities Act of 1933, as amended, in connection with the request for acceleration of the
effective date of the Registration Statement.

 The number of
prospectuses dated September 23, 2004, prospectuses dated January 13, 2005 and the prospectuses dated February 4, 2005 as distributed between September 23, 2004 and February 8, 2005 is as follows:

No. of copies dated
September 23, 2004

No. of copies dated
January 13, 2005

No. of copies dated
February 4, 2005

 To Prospective Underwriters and Dealers:

2,184

2,184

2,184

 To Institutions:

107

107

107

 To Individuals:

413

413

422

 Total:

2,704

2,704

2,713

 Sincerely,

 FIRST DUNBAR SECURITIES CORPORATION

 As Representative

 /s/ Robert L. Clark

 Robert L. Clark

 Chief Executive Officer